Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The New York Times – Business:

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

This post first appeared in The New York Times – Business. Read the original article.